Effect of treatment with inosine pranobex in acute respiratory viral infections in children
Full Text:PDF (Русский)
Abaturov AE, Volosovets AP, Yulish EI. The role of Toll-like receptors in the recognition of pathogen-associated molecular structures of infectious pathogens and the development of inflammation. Part 1. Family TLR. Zdorovʹe rebenka. 2012;(40):116-121. (in Russian).
Bulgakova VA, Balabolkin II, Sedova MS, et al. Clinical and immunological efficacy of Inosine pranobex for acute respiratory infections in children with atopic asthma. Pediatricheskaya Farmakologiya. 2010;7(3):98-105. (in Russian).
Dronov IA, Geppe NA, Malakhov AB, Kolosova NG. Inosin pranobeх: possibilities of etiotropic therapy in acute respiratory infection in children. Clinical Practice in Pediatrics. 2016;11(4):39-43. (in Russian).
Eliseeva MIu, Tsarev VN, Masikhi KN, еt al. The effectiveness of auxiliary immunotherapy in patients with immunodeficiency and frequently ill children: a systematic review and meta-analysis of the use of Inosine pranobex. RMJ. 2010;18(5):313-320. (in Russian).
Kramarev SA, Yevtushenko VV, Golubovskaya OA, Doroshenko VA. Treatment of influenza and other acute respiratory viral infections. Clinical infectology and parasitology. 2014;(11):147-155. (in Russian).
L’vova II, Grishkina LIu, Deriusheva AV, et al. Ostrye respiratornye virusnye infektsii u detei. Diagnostika, lechenie, profilaktika: uchebnoe posobie [Acute respiratory viral infections in children. Diagnosis, treatment, prevention: tutorial]. Perm: PGMA; 2014. 162 p. (in Russian).
Osidak LV, Zarubaev VV, Obraztsova EV, Erman ES, Drinevsky VP. Isoprinosin in therapy of acute respiratory viral infections in frequently ill children. Children's Infections. 2008;7(4):35-40. (in Russian).
Semenova AR, Tsarenko OE. Morbidity of children of Izhevsk with acute respiratory viral infection for 2014-2015. Theoretical and applied research in the field of natural, humanitarian and technical sciences. Collection of scientific papers. 2015:13-17. (in Russian).
Sergienko EN, Shmeleva NP, Germanenko IG, Gribkova NV. Influenza in children: clinical and epidemiological features and new therapeutic options. Novosti Meditsiny i Farmatsii. 2010;(308):15-17. (in Russian).
Smiyan OI, Bynda ТP, Dmitrova YeV, Sukharieva VA. Current etiopathogenetic and clinical-diagnostic manifestations of acute viral respiratory infections in children. Journal of Clinical and Experimental Medical Research. 2013;1(3):328-336. (in Ukrainian).
Chudakova TK, Romanovskaya AV, Mikhailova EV, Khvorostukhina NF, Tseka YuS. The choice of etiotropic therapy for acute respiratory viral infections in children. Clinical Practice in Pediatrics. 2015;10(5):77-82. (in Russian).
Chudakova TK, Mikhailova EV, Levin DYu, Karal'skiy SA, Koshkin AP. Inosine pranobex in etiotropic therapy of acute respiratory viral infections in frequently ill children. Clinical Practice in Pediatrics. 2016;11(5):62-65. (in Russian).
Chudakova TK, Mikhaylova EV, Shvedova NM. Effectiveness of antiviral therapy for acute respiratory viral infections in frequently ill children. Clinical Practice in Pediatrics. 2015;10(1):58-63. (in Russian).
Beran J, Šalapová E, Špajdel M; Isoprinosine Study (EWO ISO-2014/1) Team. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study. BMC Infect Dis. 2016 Nov 7;16(1):648. doi: 10.1186/s12879-016-1965-5.
Bohmwald K, Espinoza JA, Pulgar RA, Jara EL, Kalergis AM. Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus. Front Immunol. 2017 Nov 27;8:1643. doi: 10.3389/fimmu.2017.01643.
Campoli-Richards DM, Sorkin EM, Heel RC. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1986 Nov;32(5):383-424. doi: 10.2165/00003495-198632050-00001.
Choi E, Ha KS, Song DJ, Lee JH1, Lee KC. Clinical and laboratory profiles of hospitalized children with acute respiratory virus infection. Korean J Pediatr. 2018 Jun;61(6):180-186. doi: 10.3345/kjp.2018.61.6.180.
Fox A, Le NM, Horby P, et al. Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses. PLoS One. 2012;7(2):e31535. doi: 10.1371/journal.pone.0031535.
Hersey P, Bindon C, Bradley M, Hasic E. Effect of isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in pokeweed mitogen stimulated cultures of B and T cells. Int J Immunopharmacol. 1984;6(4):321-8.
Inosine pranobex. Available from: http://www.chemspider.com/Chemical-Structure.16736312.html. Accessed: July 29, 2018.
Lasek W, Janyst M, Wolny R, Zapała Ł, Bocian K, Drela N. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharm. 2015 Jun;65(2):171-80. doi: 10.1515/acph-2015-0015.
Majewska A, Lasek W, Mlynarczyk G. Inosine pranobex - cytotoxic activities and effect of on replication of human parainfluenza viruses (HPIV-2, HPIV-4), entroviruses (CA16, EV71) and adenoviruses (HAdV-2, HAdV-5) in vitro. Med Dosw Mikrobiol. 2015;67(2):107-13.
Moniuszko T, Rogalewska A, Chyrek-Borowska S. The effect of therapy with selected immunomodulators on interleukin-2 production by peripheral blood lymphocytes. Pneumonol Alergol Pol. 1992;60 Suppl 2:120-1.
Newton AH, Cardani A, Braciale TJ. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. Semin Immunopathol. 2016 Jul;38(4):471-82. doi: 10.1007/s00281-016-0558-0.
Schmidt S, Tramsen L, Rais B, Ullrich E, Lehrnbecher T. Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives. Oncotarget. 2018 Apr 17;9(29):20891-20907. doi: 10.18632/oncotarget.25058.
Singh H, Herndon DN. Effect of isoprinosine on lymphocyte proliferation and natural killer cell activity following thermal injury. Immunopharmacol Immunotoxicol. 1989;11(4):631-44. doi: 10.3109/08923978909005391.
Wong SS, Oshansky CM, Guo XJ, et al. Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study. J Infect Dis. 2018 Jan 4;217(2):245-256. doi: 10.1093/infdis/jix571.
You Y, Wang L, Li Y, et al. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. J Dermatol. 2015 Jun;42(6):596-601. doi: 10.1111/1346-8138.12845.
Copyright (c) 2018 CHILD`S HEALTH
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2018